193 related articles for article (PubMed ID: 14587279)
1. Papain-like lysosomal cysteine proteases and their inhibitors: drug discovery targets?
Turk D; Turk B; Turk V
Biochem Soc Symp; 2003; (70):15-30. PubMed ID: 14587279
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal cysteine proteases (cathepsins): promising drug targets.
Turk D; Guncar G
Acta Crystallogr D Biol Crystallogr; 2003 Feb; 59(Pt 2):203-13. PubMed ID: 12554931
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
[TBL] [Abstract][Full Text] [Related]
4. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
Turk B; Turk V; Turk D
Biol Chem; 1997; 378(3-4):141-50. PubMed ID: 9165064
[TBL] [Abstract][Full Text] [Related]
6. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J
Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606
[TBL] [Abstract][Full Text] [Related]
7. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
[TBL] [Abstract][Full Text] [Related]
8. Revised definition of substrate binding sites of papain-like cysteine proteases.
Turk D; Guncar G; Podobnik M; Turk B
Biol Chem; 1998 Feb; 379(2):137-47. PubMed ID: 9524065
[TBL] [Abstract][Full Text] [Related]
9. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
Mason RW; Sol-Church K; Abrahamson M
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of the unusual stability and substrate specificity of ervatamin C, a plant cysteine protease from Ervatamia coronaria.
Thakurta PG; Biswas S; Chakrabarti C; Sundd M; Jagannadham MV; Dattagupta JK
Biochemistry; 2004 Feb; 43(6):1532-40. PubMed ID: 14769029
[TBL] [Abstract][Full Text] [Related]
11. S1 subsite specificity of a recombinant cysteine proteinase, CPB, of Leishmania mexicana compared with cruzain, human cathepsin L and papain using substrates containing non-natural basic amino acids.
Alves LC; Melo RL; Sanderson SJ; Mottram JC; Coombs GH; Caliendo G; Santagada V; Juliano L; Juliano MA
Eur J Biochem; 2001 Mar; 268(5):1206-12. PubMed ID: 11231271
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
[TBL] [Abstract][Full Text] [Related]
13. Interdependency of sequence and positional specificities for cysteine proteases of the papain family.
Nägler DK; Tam W; Storer AC; Krupa JC; Mort JS; Ménard R
Biochemistry; 1999 Apr; 38(15):4868-74. PubMed ID: 10200176
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function.
Guncar G; Podobnik M; Pungercar J; Strukelj B; Turk V; Turk D
Structure; 1998 Jan; 6(1):51-61. PubMed ID: 9493267
[TBL] [Abstract][Full Text] [Related]
15. Comparative study on specificities of rat cathepsin L and papain: amino acid differences at substrate-binding sites are involved in their specificities.
Koga H; Yamada H; Nishimura Y; Kato K; Imoto T
J Biochem; 1990 Dec; 108(6):976-82. PubMed ID: 2089043
[TBL] [Abstract][Full Text] [Related]
16. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal cysteine proteases: facts and opportunities.
Turk V; Turk B; Turk D
EMBO J; 2001 Sep; 20(17):4629-33. PubMed ID: 11532926
[TBL] [Abstract][Full Text] [Related]
18. The specificity of the S1' subsite of cysteine proteases.
Ménard R; Carmona E; Plouffe C; Brömme D; Konishi Y; Lefebvre J; Storer AC
FEBS Lett; 1993 Aug; 328(1-2):107-10. PubMed ID: 8344413
[TBL] [Abstract][Full Text] [Related]
19. Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.
Therrien C; Lachance P; Sulea T; Purisima EO; Qi H; Ziomek E; Alvarez-Hernandez A; Roush WR; Ménard R
Biochemistry; 2001 Mar; 40(9):2702-11. PubMed ID: 11258881
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of human cathepsin V.
Somoza JR; Zhan H; Bowman KK; Yu L; Mortara KD; Palmer JT; Clark JM; McGrath ME
Biochemistry; 2000 Oct; 39(41):12543-51. PubMed ID: 11027133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
